This is a Validated Antibody Database (VAD) review about human CD100, based on 6 published articles (read how Labome selects the articles), using CD100 antibody in all methods. It is aimed to help Labome visitors find the most suited CD100 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD100 synonym: C9orf164; CD100; COLL4; M-sema-G; SEMAJ; coll-4; semaphorin-4D; BB18; GR3; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4D
R&D Systems
mouse monoclonal (758734) |
| In order to study the interaction between CD100 and CD72 and its role in T cell proliferation, R&D Systems CD100 antibody (R&D Systems, 758734) was used in blocking or activating experiments on human samples (fig 2a). Front Immunol (2017) ncbi |
mouse monoclonal (758726) |
| In order to study the interaction between CD100 and CD72 and its role in T cell proliferation, R&D Systems CD100 antibody (R&D Systems, 758726) was used in blocking or activating experiments on human samples (fig 2a). Front Immunol (2017) ncbi |
BioLegend
mouse monoclonal (A8) |
| In order to study the interaction between CD100 and CD72 and its role in T cell proliferation, BioLegend CD100 antibody (BioLegend, A8) was used in flow cytometry on human samples at 1:50 (fig s3). Front Immunol (2017) ncbi |
mouse monoclonal (A8) |
| In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend CD100 antibody (Biolegend, A8) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi |
Invitrogen
mouse monoclonal (eBio133-1C6 (133-1C6)) |
| In order to study the interaction between CD100 and CD72 and its role in T cell proliferation, Invitrogen CD100 antibody (eBiosciences, eBio133-1C6) was used in blocking or activating experiments on human samples (fig 2a). Front Immunol (2017) ncbi |
mouse monoclonal (eBio133-1C6 (133-1C6)) |
| In order to find cell-surface markers specific to human neutrophils, Invitrogen CD100 antibody (e- Bioscienc e, 53-1009) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi |
Miltenyi Biotec
human recombinant (REA316) |
| In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, Miltenyi Biotec CD100 antibody (Miltenyi Biotec, REA316) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi |
BD Biosciences
mouse monoclonal (30/CD100) |
| In order to study the interaction between CD100 and CD72 and its role in T cell proliferation, BD Biosciences CD100 antibody (BD, 30/CD100) was used in blocking or activating experiments on human samples (fig 2a). Front Immunol (2017) ncbi |
mouse monoclonal (30/CD100) |
| BD Biosciences CD100 antibody (BD Biosciences, 610670) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1), in ELISA on human samples (fig 2) and in western blot on human samples (fig 3). Onco Targets Ther (2016) ncbi |
mouse monoclonal (30/CD100) |
| In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, BD Biosciences CD100 antibody (BD Biosciences, 610670) was used in blocking or activating experiments on human samples at 10 ug/ml (fig 5d) and in western blot on human samples (fig 2a). J Immunol (2016) ncbi |
mouse monoclonal (30/CD100) |
| BD Biosciences CD100 antibody (BD Biosciences, 30/CD100) was used in western blot on human samples . Blood (2013) ncbi |
Sigma-Aldrich
mouse monoclonal (3B4) |
| In order to study the interaction between CD100 and CD72 and its role in T cell proliferation, Sigma-Aldrich CD100 antibody (Sigma-Aldrich, 3B4) was used in blocking or activating experiments on human samples (fig 2a). Front Immunol (2017) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments